Search for: "District of Columbia v. Washington Market Co"
Results 61 - 80
of 109
Sorted by Relevance
|
Sort by Date
28 Feb 2023, 11:55 am
The defendants had moved in limine to exclude Oreskes’ proferred historian testimony,[11] under the District of Columbia’s standard for admitting and excluding expert witness opinion testimony.[12] Oreskes’ opinion, at issue in the Mann case, was on the general basis for finding scientific research to be reliable, and that “think-tanks” (including the defendant CEI) “ignore, misrepresent, or reject” principled scientific thought on… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
25 Apr 2015, 11:03 am
Green, “Reference Guide on Epidemiology,” in Federal Judicial Center, Reference Manual on Scientific Evidence 123, 150, 168 (Washington, DC:, 1st ed., 1994) (“The relative risk from an epidemiological study can be adapted to this 50% plus standard to yield a probability or likelihood that an agent caused an individual’s disease. [read post]
11 Dec 2018, 7:08 am
A selected Federal Government candidate will be assigned to the equivalent of Executive Schedule Level V. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
12 Nov 2007, 7:50 am
Co. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
29 Jan 2018, 11:28 pm
Federal District Court Judge for the District of Columbia [read post]
7 Jan 2019, 3:45 am
A selected Federal Government candidate will be assigned to the equivalent of Executive Schedule Level V. [read post]
17 Dec 2018, 8:47 am
A selected Federal Government candidate will be assigned to the equivalent of Executive Schedule Level V. [read post]
27 Dec 2020, 9:06 pm
Glicksman, The George Washington University Law School and Alejandro E. [read post]
13 Nov 2018, 11:58 am
A selected Federal Government candidate will be assigned to the equivalent of Executive Schedule Level V. [read post]
19 Nov 2018, 11:56 am
A selected Federal Government candidate will be assigned to the equivalent of Executive Schedule Level V. [read post]
5 Jul 2010, 7:59 pm
Brown and David Matusow, Bahr, et al. v. [read post]
17 Jun 2021, 7:30 am
But why not include Chisholm v. [read post]
5 May 2022, 9:01 pm
J. 363, 368 (2021). [8] Neiman Marcus v. [read post]
26 Dec 2017, 9:30 pm
Supreme Court in Kokesh v. [read post]
December 14, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
13 Dec 2009, 8:58 pm
— Juliet Eilperin, The Washington Post, December 7, 2009 The Obama administration’s opening bid in the climate talks beginning Monday in Copenhagen is not impressing some key constituencies. [read post]
29 Aug 2018, 7:03 am
Supreme Court in South Dakota v. [read post]
9 Apr 2022, 3:01 am
Doe v. [read post]